Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Robertson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Current Topics in Microbiology and Immunology|January 1, 1995
Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignanciesK D Robertson, J Barletta, D Samid, et al.
Seminars in Cancer Biology|August 1, 1996
Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinomaR F Ambinder, K D Robertson, S M Moore, et al.
Cancer Research|September 15, 2000
The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cellsG Liang, K D Robertson, C Talmadge, et al.
Blood|March 7, 1998
Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissueQ Tao, K D Robertson, A Manns, et al.
Journal of Virology|August 8, 1998
The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveQ Tao, K D Robertson, A Manns, et al.
Oncogene|October 18, 2006
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancerS Zhong, C R Fields, N Su, et al.
Nucleic Acids Research|April 25, 2000
Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cellsK D Robertson, K Keyomarsi, F A Gonzales, et al.
Molecular and Cellular Biology|November 1, 1995
Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucialK D Robertson, S D Hayward, P D Ling, et al.
The American Journal of Pathology|August 6, 1999
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysisQ Tao, L J Swinnen, J Yang, et al.
Blood|October 15, 1996
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's diseaseK D Robertson, A Manns, L J Swinnen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Current Topics in Microbiology and Immunology|January 1, 1995
Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignanciesK D Robertson, J Barletta, D Samid, et al.
Seminars in Cancer Biology|August 1, 1996
Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinomaR F Ambinder, K D Robertson, S M Moore, et al.
Cancer Research|September 15, 2000
The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cellsG Liang, K D Robertson, C Talmadge, et al.
Blood|March 7, 1998
Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissueQ Tao, K D Robertson, A Manns, et al.
Journal of Virology|August 8, 1998
The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveQ Tao, K D Robertson, A Manns, et al.
Oncogene|October 18, 2006
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancerS Zhong, C R Fields, N Su, et al.
Nucleic Acids Research|April 25, 2000
Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cellsK D Robertson, K Keyomarsi, F A Gonzales, et al.
Molecular and Cellular Biology|November 1, 1995
Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucialK D Robertson, S D Hayward, P D Ling, et al.
The American Journal of Pathology|August 6, 1999
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysisQ Tao, L J Swinnen, J Yang, et al.
Blood|October 15, 1996
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's diseaseK D Robertson, A Manns, L J Swinnen, et al.
Pageof 3